Latest Episodes
Prostate cancer: PARP inhibitors. Part 3 - Efficacy and safety of combination therapy
Dr Tanya Dorff, a Medical Oncologist from the City of Hope Comprehensive Cancer Center and Dr Neeraj Agarwal, Medical Oncologist and Director of the...
Advanced HCC: Patients not eligible for IO - What are the treatment options?
Prof. Dr James Harding, Medical Oncologist at Memorial Sloan Kettering Cancer Center and Prof. Dr Sammy Saab, Gastroenterologist and Transplant Hepatologist at the David...
Prostate cancer: PARP inhibitors. Part 2 - Combination therapy; US and EU perspectives
Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and Dr Elena Castro,...
Prostate cancer: PARP inhibitors. Part 1 - PARPi monotherapy; US and EU perspectives
Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and Dr Elena Castro,...
Endometrial carcinoma: Systemic therapies. Part 2 - The nurses' perspective
Join Lead Nurse Andreia Fernandes and Clinical Nurse Specialist Jo Pearson as they explain how to help patients navigate the side effects of systemic...
Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective
Join world-renowned gynaecological oncology experts Dr Domenica “Ketta” Lorusso and Dr Mansoor Mirza as they explore the changing landscape of systemic treatment in endometrial...